[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 11, Issue 3 (5-2020) ::
Caspian J Intern Med 2020, 11(3): 11-0 Back to browse issues page
Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
Elnaz Faramarzi , Nayyer Jaberi , Mostafa Farahbakhsh , Alireza Ostadrahimi , Mohammad Asghari Jafarabadi , Ali Fakhari
Liver and Gastrointestinal Diseases Research center, Tabriz University of Medical sciences,Tabriz, Iran , elnazfaramarzi849@gmail.com
Abstract:   (216 Views)
Background: The present study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medication.
Methods: In this study, 60 volunteer schizophrenic patients were included.  At the onset and 6 month after treated with antipsychotic medication, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weigh, waist circumference (WC), and blood pressure   were determined. We defined Mets according to ATPIII criteria.
Results: After 6 month treatment with antipsychotics drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (P<0.05).  We found that percentage of patients with high WC, low HDL levels, and Mets increased after treatment which was statistically significant (P<0.05).
Conclusion: It is recommended that nutritional and life style changes intervention should be implanted for schizophrenic patients undergoing treatment.  
Keywords: schizophrenic patients, metabolic syndrome, metabolic syndrome components
Type of Study: Original Article | Subject: psychiatry
Received: 2019/08/27 | Accepted: 2020/02/3 | Published: 2020/05/21
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Faramarzi E, Jaberi N, Farahbakhsh M, Ostadrahimi A, Asghari Jafarabadi M, Fakhari A. Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication. Caspian J Intern Med. 2020; 11 (3) :11-0
URL: http://caspjim.com/article-1-2035-en.html

Volume 11, Issue 3 (5-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 4144